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Abstract – Bone remodelling is carried out by ‘bone multicellular units’ (BMUs) in which active osteoclasts and active
osteoblasts are spatially and temporally coupled. The refilling of new bone by osteoblasts towards the back of the
BMU occurs at a rate that depends both on the number of osteoblasts and on their secretory activity. In cortical bone, a
linear phenomenological relationship between matrix apposition rate and BMU cavity radius is found experimentally.
How this relationship emerges from the combination of complex, nonlinear regulations of osteoblast number and
secretory activity is unknown.
Here, we extend our previous mathematical model of cell development within a single cortical BMU to investigate
how osteoblast number and osteoblast secretory activity vary along the BMU’s closing cone. The mathematical
model is based on biochemical coupling between osteoclasts and osteoblasts of various maturity, and includes the
differentiation of osteoblasts into osteocytes and bone lining cells, as well as the influence of BMU cavity shrinkage
on osteoblast development and activity. Matrix apposition rates predicted by the model are compared with data from
tetracycline double labelling experiments. We find that the linear phenomenological relationship observed in these
experiments between matrix apposition rate and BMU cavity radius holds for most of the refilling phase simulated
by our model, but not near the start and end of refilling. This suggests that at a particular bone site undergoing
remodelling, bone formation starts and ends rapidly, supporting the hypothesis that osteoblasts behave synchronously.
Our model also suggests that part of the observed cross-sectional variability in tetracycline data may be due to different
bone sites being refilled by BMUs at different stages of their lifetime. The different stages of a BMU’s lifetime (such as
initiation stage, progression stage, and termination stage) depend on whether the cell populations within the BMU are
still developing or have reached a quasi-steady state while travelling through bone. We find that due to their longer
lifespan, active osteoblasts reach a quasi-steady distribution more slowly than active osteoclasts. We suggest that this
fact may locally enlarge the Haversian canal diameter (due to a local lack of osteoblasts compared to osteoclasts) near
the BMU’s point of origin.
Key words: bone remodeling, basic multicellular unit, closing cone, matrix apposition rate, tetracycline labeling,
computational modeling
1 Introduction
Bone remodelling renews bone tissue in a spatially and tempo-
rally discrete fashion by means of ‘basic multicellular units’
(BMUs). In a BMU, osteoclasts (bone-resorbing cells) create
a resorption cavity called the ‘cutting cone’ and osteoblasts
(bone-forming cells) refill this cavity, forming a so-called
‘closing cone’ [1,2]. The action of osteoclasts and osteoblasts
in a BMU is well coordinated such that bone formation closely
follows bone resorption [1, 3–5]. During remodelling, bone
may be either gained or lost depending on (i) the final balance
of bone turned over by a BMU, i.e., the amount of bone refilled
compared to the amount of bone resorbed; and (ii) the number
of active BMUs, due to the temporary BMU cavities that exist
before refilling by the osteoblasts has completed [6, 7]. These
mechanisms of gain or loss depend in particular on a fine
regulation and timing of bone refilling in a BMU. Under-
refilling of the BMU cavity occurs for instance in advanced
stages of osteoporosis [3, 4, 8, 9], whilst over-refilling of the
BMU cavity occurs in sclerosing bone disorders such as scle-
rosteosis, van Buchem disease, and high-bone-mass pheno-
1Corresponding author. Email address:
<firstname>.<lastname>@uwa.edu.au
type [10].1 How bone refilling is controlled in a BMU remains
poorly characterised. In particular the relative contributions of
osteoblast number and osteoblast secretory activity at different
phases of the refilling process are unknown. In this paper we
develop a computational model of a BMU to investigate these
contributions. The model will focus on a perfectly cylindrical
geometry. Experimental data on the refilling dynamics in cor-
tical bone are usually deduced from regular, cylindrical BMUs.
However, general considerations on the refilling dynamics of
BMUs (Section 2.1) will be presented in an arbitrary geometry
to elucidate how experimental measurements of osteoblast
secretory activity could be deduced from irregular BMUs (see
also the Conclusions).
The matrix apposition rate at the back of a cortical BMU
(i.e., the rate of change of the BMU cavity radius (R)) depends
both on the surface density of active osteoblasts ρOBa and
on their secretory activity kform (i.e., the volume of osteoid
secreted per osteoblast per unit time) (see Section 2.1):
∂
∂ t R =−kform ρOBa . (1)
1Over-refilling occurs mainly on trabecular and endosteal surfaces. How-
ever, a net bone gain is possible in cortical BMUs that follow a pre-existing
Haversian canal while reducing the canal’s size (‘type II osteon’) [11, 12].
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Experimentally, matrix apposition rates are estimated by dy-
namic histomorphometry techniques such as tetracycline dou-
ble labelling [13–20]. In cortical bone, such double labelling
experiments reveal that matrix apposition rate and BMU cavity
radius are linearly related [15, 16, 18, 19]:
∂
∂ t R =−C R. (2)
How this linear phenomenological relationship arises from
underlying biological mechanisms in Eq. (1) is still uncertain.
Both the density of osteoblasts ρOBa and their secretory activ-
ity kform vary as refilling proceeds [21]. The surface density
of osteoblasts in the BMU ρOBa depends on complex coupling
to osteoclasts [2–5], bone surface availability, embedment in
the bone matrix (transition to an osteocytic phenotype) [22],
and apoptosis [2–4]. The rate of osteoid secretion by a single
osteoblast kform depends on phenotype (transition to a bone
lining cell), the cell’s protoplasmic volume [21, 23, 24], and
may be regulated by the availability of nutrients, signalling by
local regulatory molecules and hormones [3–5], the proximity
of the blood vessel [1], and/or the local geometry of the bone
substrate [25–27].
Few works have investigated the number of osteoblasts and
their level of secretory activity in a BMU in vivo [21, 24, 28],
as also observed in [25]. In Refs [21, 24, 28], the secretory
activity of osteoblasts was deduced from measurements of cell
surface density and matrix apposition rate, and use of Eq. (1).
Marotti et al. [21] performed serial sections of cortical BMUs
to do so, but a quantitative analysis is only presented for three
cross-sectional slices.
The comparison of Eq. (1) and Eq. (2) emphasises the
implicit influence of the BMU cavity radius R on the popu-
lation of osteoblasts and/or on their secretory activity. Thus,
changes in local bone geometry and changes in osteoblasts are
interdependent. Influences of the local bone geometry may
appear through signalling (e.g. by osteocytes [27, 29]), and
through the availability of bone surface to active osteoblasts.
The experimental assessment of geometrical influences on
bone formation in vivo is challenging due the difficulty of
controlling the geometry, but substrate geometry was shown to
play an important role in an in vitro system [26], and it could
be responsible for the difference between matrix apposition
rates in cortical and in trabecular bone [27].
In this paper, we develop a mathematical model of a cortical
BMU with the aim to understand (i) how osteoblast population
size and osteoblast secretory activity vary with the various
stages of the refilling process in a BMU; and (ii) how a linear
relationship between matrix apposition rate and BMU cavity
radius, Eq. (2), arises from Eq. (1) while accounting for com-
plex, nonlinear biochemical and geometric regulatory mech-
anisms of osteoblast development. Specifically, the implicit
dependence of ρOBa upon R will be investigated by modelling
at the cellular level the influence of the evolving cavity radius
on the development of osteoblasts. The implicit dependence
of kform upon R will be extrapolated from experimental data
from Ref. [21].
Determining how osteoblast number and osteoblast secre-
tory activity vary along a BMU is critical to fully understand
how bone refilling is regulated in a BMU. This has important
implications for several disorders of bone remodelling and
their treatment, in particular for osteoporosis [8]. Geometric
influences on bone cell development are also important to
determine in order to assess the true contribution of biochem-
ical regulatory systems. Experimental challenges associated
with the study of geometric influences in vivo emphasise the
need for accurate computational models that account for these
geometric influences.
Mathematical and computational models of cell popula-
tions in bone remodelling are improving as a tool to assess
the complexity of the spatio-temporal dynamics of cell–cell
and cell–bone interactions. In recent years, several teams of
researchers have developed such mathematical models, either
focused on the tissue scale [30–35] or on the scale of a
single BMU [36–42]. To our knowledge, the only previous
mathematical model investigating the refilling process of a
BMU in some detail is that of Ref. [36]. However, in Ref. [36],
the resorption process and the start of the refilling process
are not modelled. The refilling process starts instead with an
assumed initial population of active osteoblasts.
The model we develop here is based on biochemical regu-
lation of osteoclast and osteoblast development across various
maturity stages. It extends our previous model [41] by adding
important influences on the development of osteoblasts in the
BMU, namely, a geometrical effect of cavity shrinkage on the
density of osteoblasts, an osteoblast-to-osteocyte transition
(that likewise depends on the geometry), and an osteoblast-
to-bone lining cell transition at the end of the refilling pro-
cess. Accounting for these additional influences enables us to
retrieve a combined evolution of osteoblast density and BMU
cavity radius compatible with the linear decrease of matrix ap-
position rate with R observed from tetracycline experiments,
Eq. (2). The direct comparison of our model with tetracycline
data enables us to emphasise limitations of such data. Our
model also provides insights into how the BMU evolves from
its initiation stage (early-life) to its progression stage (quasi-
steady state, mid-life). Finally, in contrast to our previous
model [41], the present model is calibrated for osteoclast,
osteoblast, and precursor cell numbers in the BMU [2, 43],
and for osteoblast surface densities at three radii of the BMU
cavity [21].
2 Methods
We first provide a derivation of Eq. (1), generalised to BMUs
of any shape (Section 2.1). This derivation does not rely on a
specific model of osteoblast population and activity. We then
present our model of osteoclast and osteoblast development
within the BMU (Section 2.2), and apply it to Eq. (1) to
determine matrix apposition rates in the closing cone of the
BMU.
2.1 Bone refilling dynamics
We consider a thin slice of bone exhibiting the refilling
process in the closing cone of a BMU (Figure 1a). The slice
corresponds to a local region of interest and is assumed to be
(i) transverse to the BMU’s longitudinal axis (x); (ii) of small
thickness ∆x; and (iii) at a fixed position x in bone (but the
state of the BMU at various positions x will be investigated).
As the BMU progresses forward along x, gradually moving
away from the slice, the BMU cavity (Cv) seen in the slice
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Figure 1 – (a) The slice of bone of thickness ∆x at the fixed position x reveals a transverse cross-section of the BMU (which itself progresses along the x axis
at speed vOCa ). The section exibits the ring-like cross-sectional area of newly-formed bone, the cross-sectional area of the cavity S(x, t), the cross-sectional
perimeter of the cavity P(x, t), and the ring-like cross-sectional area containing active osteoblasts SOBa (x, t), of width hOBa . (b) Four stages of the formation
phase of the BMU seen in transverse cross-section at the fixed location x in bone as the BMU progresses forward along x: 1. Onset of formation: differentiation of
pre-osteoblasts (OBp) into active osteoblasts (OBa); cavity radius equal to the cement line radius Rc; 2. Early stage of formation, showing that some osteoblasts
have become osteocytes (OCY) embedded in the bone matrix; cavity radius R(x, t); 3. Mid stage of formation; r denotes a radial coordinate; 4. End of formation:
the active osteoblasts have become bone lining cells (LC) and the cavity radius is the Harversian canal radius RH.
refills with time due to the local production of osteoid by
active osteoblasts (Figure 1b). The total volume of osteoid
produced per unit time in the slice is kform(x, t)∆NOBa(x, t),
where kform(x, t) [µm3/day] is the volume of osteoid secreted
per osteoblast per unit time, and ∆NOBa(x, t) is the number
of active osteoblasts in the slice. The production of osteoid
reduces the cross-sectional area of the BMU cavity S(x, t)
(Figure 1a) according to:
∂
∂ t S(x, t)∆x =−kform(x, t) ∆NOBa(x, t). (3)
Dividing Eq. (3) by ∆x, this can be expressed as:
∂
∂ t S(x, t) =−kform(x, t) ρOBa(x, t) P(x, t), (4)
where
ρOBa(x, t) =
∆NOBa(x, t)
∆xP(x, t)
(5)
is the local surface density of active osteoblasts and P(x, t) is
the cross-sectional perimeter of the BMU cavity (Figure 1a).
For a perfectly cylindrical cortical BMU of cavity radius
R(x, t), P(x, t) = 2piR(x, t), S(x, t) = piR(x, t)2, and so ∂∂ t S =
2piR ∂∂ t R. In this case, Eq. (4) specialises to Eq. (1):
∂
∂ t R(x, t) =−kform(x, t) ρOBa(x, t). (6)
The refilling dynamics(4) and (6) are based on geometrical
considerations only. These expressions do not depend on a
specific model of osteoblast surface density ρOBa or osteoid
secretion rate kform. In this paper, we will restrict to the
refilling dynamics of cylindrical BMUs, Eq. (6).
2.2 Computational model for osteoblast distri-
bution in the BMU
The mathematical model presented in this paper is based
on our previous mathematical model of osteoclast and os-
teoblast development in a cortical BMU in one spatial di-
mension (the BMU longitudinal axis) [41]. Biochemical
coupling between osteoclasts and osteoblasts and migration
properties of these cells are implemented via the material
balance equation expressed for each cell type and signalling
molecule considered [41]. These equations integrate source
and sink terms due to cell differentiation and cell apoptosis,
receptor–ligand binding reactions, protein expression by cells,
micro-environmental protein degradation, as well as transport
terms due to cell migration and protein diffusion. The core
assumptions of the model are summarised below with the
network of biochemical regulation illustrated in Figure 2.
Further details are presented in Appendix A, including all the
governing equations and parameters of the model.
BMU cavity. The BMU cavity is assumed to be perfectly
cylindrical (rotation-symmetric with respect to the x axis).
Only the refilling of the cavity is considered in this paper.
The cavity radius R(x, t) is assumed to decrease from an
initial value equal to the cement line radius Rc up to the
Haversian canal radius RH (at most) due to matrix deposition
by osteoblasts (Eq. (6)).2 The two parameters Rc ≈ 100 µm
and RH ≈ 20 µm correspond to human average values (see
Table 3 in Appendix A). No cross-sectional variability is
assumed for Rc and RH in this paper. The model results
will be compared with tetracycline data (Figure 4) that have
been first normalised adequately to remove the influence of
cross-sectional variability in cement line and Haversian canal
radii [20], and that have been then rescaled to the values Rc
and RH assumed here.
Osteoclasts. Two stages of osteoclast development are mod-
elled: pre-osteoclasts (OCp) and active osteoclasts (OCa) (Fig-
ure 2):
• OCps are distributed around the tip of a blood vessel
growing at a rate commensurate with the BMU pro-
gression (20–40 µm/day) [1, 2, 11, 44], taken to be
30 µm/day;
2When R = RH , osteoblast secretory activity is assumed to stop (see the
Osteoblast section below), but refilling may stop before R reaches RH if the
population of osteoblasts goes extinct.
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Figure 2 – Biochemical regulation of osteoclast and osteoblast development in the BMU used in the model.
• OCps differentiate into OCas at a rate DOCp accelerated by
activation of the receptor–activator of nuclear factor κB
(RANK) by the ligand RANKL [45, 46];
• OCas undergo apoptosis at a rate AOCa accelerated by
transforming growth factor β (TGFβ) [31, 45];
• OCas progress forward along the x axis due to bone
resorption, at a rate vOCa = 30 µm/day [1, 2, 11].
As a result, the material balance equation for the local volu-
metric density of active osteoclasts OCa(x, t) [mm−3] is [41]:
∂
∂ t OCa =DOCp(RANKL)OCp−AOCa(TGFβ)OCa− ∂∂x (OCa vOCa).
(7)
Osteoblasts. Three stages of osteoblast development are
modelled: uncommitted osteoblast progenitors (such as mes-
enchymal stem cells) (OBu), pre-osteoblasts (OBp) and active
osteoblasts (OBa). Osteoblasts may also become osteocytes
(OCY) or bone lining cells (LC) (Figure 2):
• OBus are distributed around the tip of the blood vessel
growing along x at 30 µm/day, similarly to OCps [1, 2,
44, 47];
• OBus differentiate into OBps at a rate DOBu accelerated by
TGFβ [2, 5, 48, 49];
• OBps differentiate into OBas at a rate DOBp inhibited by
TGFβ [31, 41];
• OBps and OBas are stationary with respect to bone [1, 2,
41, 50, 51].
The following features of osteoblast development are added in
the present work compared to Ref. [41] (see Appendix A for
more details):
• Secretory activity. The secretory activity of OBas depends
on the current cavity radius:
kform(x, t) = k˜form
(
R(x, t)
)
[µm3/day] (8)
The function k˜form elucidating this dependence is extrap-
olated from measurements from [21]. The activity of
osteoblasts is thereby assumed to vary continuously (e.g.,
no work–rest cycles) [1, 11, 52];
• Osteoblast-to-osteocyte transition. OBas transition to
OCYs at a rate σprod.OCY that depends on the density of OBas
and on R [22,36,53], such that a uniform density of OCYs
of 20000/mm3 is produced [11];
• Osteoblast-to-bone lining cell transition. OBas transition
to LC when R reaches a target Haversian canal radius
RH. This is modelled by a sudden, but continuous drop
in OBas’ secretory activity k˜form(R) near RH [1] (see
Figure 6 in Appendix A);
• Osteoblast apoptosis. OBas undergo apoptosis at a con-
stant rate AOBa calibrated so as to eliminate osteoblasts
‘in surplus’ [1, 2];
• Geometric influence of BMU cavity shrinkage. The
shrinking BMU cavity confines OBas into a smaller space,
which increases the density of OBas at a rate G that
depends on R [36, 54].
The total change in the density of OBas is a superposition of
all of the influences listed above, which may compensate each
other. In particular, the density of OBas may still decrease
during BMU cavity shrinkage if there is a concurrent decrease
in the number of OBas in the cavity. As a result of the above
assumptions, the material balance equations for the local
volumetric densities of pre-osteoblasts OBp(x, t) and active
osteoblasts OBa(x, t) are:
∂
∂ t OBp =DOBu(TGFβ)OBu−DOBp(TGFβ)OBp (9)
∂
∂ t OBa =DOBp(TGFβ)OBp−AOBa OBa+GOBa−σprod.OCY (10)
The last three terms of Eq. (10) replace the constant elimi-
nation rate of OBas used in Ref. [41], which was previously
modelling all the depletion pathways of the pool of active
osteoblasts (i.e., osteoblast-to-osteocyte, osteoblast-to-bone
lining cell, and apoptosis). The precise form of these new
terms (in particular, their dependence on the cavity radius
R(x, t)) is presented in Appendix A.
Signalling molecules and binding reactions. The bio-
chemical coupling between osteoclasts and osteoblasts is me-
diated in the model by RANKL and TGFβ, as in Refs [31, 41]
(TGFβ may also represent other regulatory factors stored in
the bone matrix, such as insulin-like growth factors (IGF), see
Figure 2). RANKL is influenced by osteoprotegerin (OPG) and
parathyroid hormone (PTH). All of RANKL, OPG and TGFβ are
driven by cellular actions (Figure 2):
• RANKL is expressed on the membrane of OBps; OPG is
expressed by OBas; RANK is expressed on OCps [41, 55,
56];
• RANKL binds both RANK and the decoy receptor OPG
competitively (RANK signalling on OCp is thereby dimin-
ished in presence of OPG) [45, 46];
• PTH promotes the expression of RANKL and inhibits the
expression of OPG [57]. In this work, a constant level of
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systemic PTH is assumed, uniformly distributed along the
BMU [41].
• TGFβ is stored in the bone matrix at a constant concen-
tration nboneTGFβ; it is released in the micro-environment in
proportion to bone resorption by OCas [45, 48, 49];
• All of the signalling molecules RANKL, OPG, and TGFβ
undergo micro-environmental degradation at a constant
rate. A constant number of RANK per OCp is assumed.
Binding reactions between receptors and ligands are consid-
ered through mass action kinetics with reaction rates pro-
portional to population sizes. The acceleration or inhibition
of a cell behaviour by a ligand, such as differentiation rate,
apoptosis rate, and protein production rate, is assumed to
occur in proportion to the receptor occupancy on the cell (see
Appendix A and Ref. [41] for further details).
Surface density and volumetric density of active os-
teoblasts. Biochemical processes of cell development are
best described in terms of volumetric concentrations of sig-
nalling molecules and volumetric density of cells. (To align
with common practice, we use the terminology ‘concentra-
tion’ for signalling molecules and ‘density’ for cells, even
though both terminologies refer to the same units, i.e., number
per unit volume.) Indeed, biochemical reaction rates depend
on the probability of encounter of the interacting biochemical
compounds. This probability depends in turn on how closely
packed the compounds are, and so, on their local concentra-
tion or density (i.e., their number per unit volume) [58].
The material-balance equations (7)–(10), which involve
biochemical reactions, are therefore written in terms of volu-
metric densities. However, the refilling dynamics described by
Eq.(6) involves the surface density ρOBa of active osteoblasts.
To relate the volumetric density OBa to the surface density
ρOBa , we use the fact that active osteoblasts in a BMU form a
single layer of cells against the cavity walls [21], of thickness
hOBa (the height of an active osteoblast). In the cross section,
active osteoblasts are thus confined to an annulus of cross-
sectional area SOBa (Figure 1a). Within this annulus, active
osteoblasts are distributed fairly uniformly, and so SOBa con-
stitutes an appropriate representative surface element to define
the volumetric density of active osteoblasts [58, Chap. XIV],
i.e.:
OBa(x, t) =
∆NOBa(x, t)
∆x SOBa(x, t)
= ρOBa(x, t)
P(x, t)
SOBa(x, t)
, (11)
where Eq. (5) has been used for the second equality. In a
cylindrical BMU, P(x, t) = 2piR(x, t) and
SOBa(x, t) = pi
[
R(x, t)2− (R(x, t)−hOBa)2
]
. (12)
The relation (11) between osteoblast surface density and
volumetric density becomes:
ρOBa(x, t) = OBa(x, t) hOBa
(
1− hOBa
2R(x, t)
)
. (13)
Substituting Eq. (13) into Eq. (6) gives:
∂
∂ t R(x,t) =−kform(x,t)OBa(x,t)hOBa
(
1− hOBa
2R(x,t)
)
. (14)
We note that in the above relationship, the geometric factor(
1− hOBa2R(x,t)
)
accounts for the nonzero curvature 1/R of the
cavity (a flat surface has zero curvature, corresponding to the
limiting case 1/R→ 0). However, both kform and OBa may still
depend on R.
Calibration of the cell populations and validation of the
model. Quantitative data on the distribution of cells and
their total number in cortical BMUs are relatively sparse [2,
21, 43, 47]. Some of the data useful to calibrate and validate
our model are derived from animal models, such as cell
surface densities and osteoid secretion rates at different BMU
cavity radii (dogs) [21], total cell numbers (dogs) [43], and
tetracycline double labelling radii (sheep) [20]. Some of
these data were rescaled to (pseudo-)human values according
to known (or suspected) cross-species differences [59] (Ap-
pendix A). We calibrated our model such that the numerical
cell distribution profiles are in reasonable agreement with the
following:
• The total number of precursor cells (NOBu ,NOCp ) in steady
state is about 20;
• The total number of active osteoclast nuclei (NOCa ) in
steady state is about 100 [43]. (Here and in Ref. [41],
OCas represent mononucleated entities incorporated in a
multinucleated active osteoclast. Multinucleated active
osteoclasts are composed of about 10 nuclei [43];)
• The surface density of active osteoblasts (ρOBa ) in steady
state coincides with data reported by Marotti et al. [21]
at three different cavity radii (appropriately rescaled),
whilst the total number of active osteoblasts (NOBa ) in
steady state is in the range 2000–6000 [11, 36, 43] (see
also Discussion, Section 4).
To calibrate the model against the number of active osteo-
clast nuclei and precursor cells in the steady-state BMU, the
cell densities OCa(x, t), OCp(x, t) and OBu(x, t) were integrated
over the BMU cavity volume at t = 150 days. Appropriate
changes in model parameter values were determined to enable
these cell numbers to match the values mentioned above
(Appendix A, Eqs (22)).
To calibrate the model against the surface densities of active
osteoblasts at three different cavity radii (Table 2) and against
the total number of active osteoblasts, we modified (i) the rate
of osteoblast apoptosis AOBa ; (ii) the model parameters related
to the scaling factor αOBa (Appendix A); and (iii) the (canine-
to-human) scaling factor αkform (Appendix A). The apoptosis
rate AOBa influences the spatial rate of decrease of the os-
teoblast distribution at the back of the BMU [41]. The factor
αOBa scales the value of the density at each location along the
BMU uniformly. The scaling factor αkform enables to modify
the total number of active osteoblasts in the steady state BMU
(e.g., increasing αkform reduces NOBa ). The total number of
pre-osteoblasts was obtained by integrating OBp(x, t) over the
cavity volume and the total number of active osteoblasts was
obtained by integrating the surface density ρOBa(x, t) over the
cavity–bone surface in the steady state BMU (at t = 150 days).
The calibrated model was validated against three indepen-
dent sets of experimental data: (i) the density of bone lining
cells reached at the end of the formation phase; (ii) the length
of the closing cone of the BMU; (iii) tetracycling double
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labelling data (see Sections 3 and 4).
Governing equations and numerical simulations. Equa-
tions (7)–(10) and Eq. (14) govern the dynamics of the cell
populations in the BMU and of the BMU cavity refilling. These
equations are interdependent and involve binding reactions for
the concentrations of RANKL, OPG, and TGFβ. TGFβ has a
production rate that depends on osteoclast resorption, but the
dynamics of the signalling molecules RANKL and OPG is fast
compared to the characteristic times of cell behaviours [41].
The balance equations of RANKL and OPG can be taken
in a quasi-steady state, enabling the concentration of these
signalling molecules to become algebraic expressions of the
variables OBp,OBa,OCa, and TGFβ [41].
The equations governing the evolution of the whole system
are presented in Appendix A, see Eqs (23)–(26). These
equations together with Eq. (14) form a coupled system of
five partial differential equations (PDEs). These PDEs were
solved numerically to evolve the system for 150 days from an
initial condition with a small, localised population of active
osteoclast nuclei (OCas) and given distributions of OBus and
OCps concentrated around the (growing) tip of the blood vessel
of the BMU, as in Ref. [41]. The initial cavity radius was
set to the cement line radius Rc as only the refilling of the
cavity is considered in this paper. The point of origin of
the BMU (i.e., the center of the initial distribution of active
osteoclasts and precursor cells) was set at x0 = −4.85 mm.
The PDEs were solved in a co-moving frame attached to the
BMU with the following boundary conditions: the density of
pre-osteoblasts and active osteoblasts was set to zero at the
(moving) front of the BMU; the density of active osteoclasts
and the concentration of TGFβ were set to zero at the back
of the BMU. The numerical algorithm used was that of the
‘method of lines’ of Mathematica’s PDE solver ‘NDSolve’
with a spatial discretisation of at least 2000 points, ensuring
absolute and relative tolerances of 10−4 [60].
3 Results
Evolution of the cell distribution profiles: BMU initiation
and quasi-steady state. The distribution of cells along the
longitudinal x axis evolves from the initial condition into a
stable multicellular travelling-wave-like structure (Figure 3a–
c). After an initiation phase during which the shapes of the cell
distribution profiles develop and stabilise, this multicellular
structure progresses forward through bone without changing
shape (‘quasi-steady’ state), with osteoclasts towards the front
and osteoblasts towards the back, as in a BMU (Figure 3c).
Each cell type reaches a stable spatial distribution at a
different rate. The population of active osteoclasts quickly
increases from almost zero to its quasi-steady state within
around 10 days. In contrast, the population of active os-
teoblasts takes about 130 days until its spatial distribution
reaches a stable shape. However, the shape of the front of the
OBa distribution profile (i.e., the part ahead of the maximum)
takes less time to stabilise, approximately 50 days. The
comparison of Figures 3b and 3c shows that the front of the
OBa distribution profile (including a part extending beyond the
maximum) has reached a stable shape by t = 75 days. In fact,
the time required for the front of the OBa distribution profile
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Figure 3 – (a)–(c) The profiles of cell densities along the BMU’s length (top of
each panel) and the corresponding shape of the closing cone (bottom of each
panel) are shown at time (a) t = 0 days (initial condition), (b) t = 75 days, and
(c) t = 150 days. To ensure that all cell densities are visible, OBu, OCp, and
OCa were multiplied by a factor 20. The active osteoblast surface density ρOBa
and bone lining cell surface density ρLC are also shown (dot-dashed lines). In
(b), individual osteoid secretion rate kform has not yet dropped enough for
OBa to differentiate into LC. In (c), an OBa → LC transition takes place as
indicated by the arrow. The arrow starts and ends where kform is 90% and
10% of the drop near RH in Figure 6 (see also panel (d)). The crosses in (c)
correspond to the experimental data of osteoblast surface density from [21]
listed in Table 2, scaled to human values. (d) Profile of osteoid secretion rate
kform(x, t) by active osteoblasts at t = 150 days. The grey lines indicate where
kform is 90% and 10% of the drop near RH in Figure 6 (OBa→ LC transition).
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to reach a steady shape (50 days) corresponds to the time
required to increase the population of active osteoblasts from
zero to its maximum value when the BMU is initiating. All the
bone traversed by the BMU at times t & 50 days, i.e. all the
bone located at x & −4.1 mm, experiences the full extent of
the population of both active osteoclasts and active osteoblasts
(−4.1 mm corresponds to the position of the maximum of the
active osteoblast population at t = 50 days). The temporal
pattern of osteoclast and osteoblast development seen at these
fixed locations in bone whilst traversed by the BMU is no
longer developing as during the initiation stage of the BMU. At
these locations, the BMU is seen in a quasi-steady state, and the
time required to increase the population of active osteoblasts
to its maximum value is reduced to about 26 days (see below).
BMU cavity shape (closing cone). The BMU cavity shown
at the bottom of each graph in Figure 3a–c progressively
refills as soon as active osteoblasts are generated. During
the initiation stage of the BMU, the shape of the closing cone
varies. When the BMU reaches its quasi-steady state, the
closing cone is fully formed and progresses forward without
changing shape, in association with the quasi-steady popula-
tion of active osteoblasts. Matrix apposition rate is strongly
reduced when the cavity radius reaches values close to the
‘target’ Haversian canal radius RH = 20 µm. The variation of
osteoid secretion rate per osteoblast along the BMU, kform(x, t),
is shown at t = 150 days in Figure 3d. The locations at which
kform is 90% and 10% of the magnitude of the drop near R =
RH in Figure 6 (see Appendix A) are also shown (gray lines).
These locations indicate the transition of active osteoblasts
(OBas) into bone lining cells (LC) and correspond to the start
and end of the OBa → LC transition arrow in Figure 3c. This
transition represents the end of the (active) BMU closing cone,
and the start of the (quiescent) newly-formed osteon.
Length of the closing cone. Considering the start of the
closing cone in Figure 3c to be around x ≈ −0.5 mm and the
end of the closing cone to correspond to the intersection of the
active osteoblast surface density and bone lining cell density
at around x ≈ −3 mm, the total length of the closing cone of
the simulated BMU is about 2.5 mm.
Osteoblast density and total cell numbers in the BMU. In
the steady-state BMU shown in Figure 3c, the population of
active osteoblasts (OBa, blue) rises sharply at the start of
the refilling process, i.e. between x ≈ −0.35 mm and x ≈
−1.12 mm, the latter being the position of the maximum
density. This spatial interval corresponds to a time interval
of about 26 days
(≡ (−1.12+0.35) mm30 µm/day ). The peak population
of active osteoblasts is reached near the disappearance of the
population of pre-osteoblasts (OBp, cyan). Past this point,
the distribution of active osteoblasts exhibits a slow, pseudo-
linear decrease (from right to left) up to the point where active
osteoblasts transition to bone lining cells (LC→ OBa arrow).
The dot-dashed blue line in Figure 3c represents the surface
density of active osteoblast ρOBa and the constant surface
density of bone lining cells ρLC = 2300/mm2 [11]. Surface
densities ρOBa < 2300/mm2 are shaded as they do not corre-
spond to real active osteoblasts: at these locations, osteoblasts
are assumed to have become bone lining cells of constant
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Figure 4 – Matrix apposition rate versus BMU cavity radius obtained from
our model (lines) and from tetracycline experiments (dots). The exact matrix
apposition rate
∣∣ ∂
∂ t R(x, t)
∣∣ versus R1 ≡ R(x, t) is shown at position x =
−3.5 mm in bone (solid grey line). The approximate matrix apposition rates∣∣ R2−R1
∆t
∣∣ ≡ ∣∣ R(x,t+∆t)−R(x,t)∆t ∣∣ versus R1 ≡ R(x, t) are shown at x = −2.5 mm,−3.5 mm, −4.5 mm, −4.65, and −4.7 mm for a fixed interval ∆t = 10 days.
Data points are taken from Ref. [20, Fig. 2] and have been appropriately
rescaled to human average BMU sizes (see text).
density no longer secreting osteoid and no longer undergoing
apoptosis. The transition from active osteoblasts to bone
lining cells (driven by the current value of the BMU cavity
radius) occurs precisely when the surface density of active
osteoblasts reaches values around 2300/mm3.
With the model parameters listed in Table 3 in Appendix A,
the total number of each cell type found in the simulated BMU
is (up to rounding approximations):
NOCa ≈ 100, NOCp ≈ 20, NOBu ≈ 20 (15)
NOBp ≈ 11100, NOBa ≈ 5200. (16)
The experimental data on osteoblast surface density at
different cavity radii, scaled to correspond to human average
BMUs (crosses in Figure 3c), are matched by the calibrated
numerical surface density ρOBa .
Tetracycline double labelling data. In Figure 4 we plot the
‘exact’, instantaneous matrix apposition rate | ∂∂ t R(x, t)| versus
R(x, t) at x = −3.5 mm (solid grey line) and the approxi-
mate, average matrix apposition rates (MAR)
∣∣R(x,t+∆t)−R(x,t)
∆t
∣∣
versus R(x, t) obtained in our simulations during refilling
when t evolves from 0 to 150 days. The effect of sampling
the radii at various positions x in bone is shown (solid and
interrupted black lines), whilst the time interval ∆t = 10 days
(corresponding to the interval between tetracycline injections
in Ref. [20]) is kept fixed. These results are compared to
experimental data from Ref. [20]. This data was collected in
sheep and plotted in Ref. [20, Fig. 2] as MAR versus “percent
unfilled”, i.e., the percent of bone thickness remaining to
deposit so as to reach the sheep Haversian canal radius. In
Figure 4, we rescaled this “percent unfilled” data to human-
sized BMU cavity radii, such that 100% unfilled corresponds
to the cement line radius Rc = 100 µm and 0% unfilled
corresponds to the Haversian canal radius RH = 20 µm (see
Eq. (20) in Appendix A).
Tetracycline double labelling data is sometimes presented
as a plot of the data pairs (R1,R2) [16, 19, 20]. In Figure 5
we plot the trajectory of the radii pairs
(
R(x, t),R(x, t +∆t)
)
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Figure 5 – Parametric plots of cavity radius pairs (R1,R2) with R1 = R(x, t)
and R2 = R(x, t +∆t) obtained from our model at a fixed location in bone
(x = −4 mm) when t evolves from 0 to 150 days. The figure shows the
effect of choosing different time intervals ∆t = 10 days, 12 days, and 15 days
(corresponding to typical time intervals between tetracyline injections). The
calculated curves intersect with the diagonal at the onset of formation and at
completion of formation.
obtained during refilling for various time intervals ∆t when t
evolves from 0 to 150 days at the fixed location x=−3.5 mm.
4 Discussion
Cell distribution profiles within the BMU. The emergence
and progression of structured cell distribution profiles models
the initiation and quasi-steady phases of a cortical BMU. A
key role is played by the biochemical coupling between the
bone cells and by the cell migration properties to explain the
emergence and stability of the BMU [41]. The cells present
initially at t = 0 generate a biochemical positive feedback
loop, captured in the governing equations: the OCas free
TGFβ from the bone matrix into the microenvironment, which
promotes the differentiation of OBus into OBps. The ligand
RANKL expressed on OBps promotes in turn the differentiation
of OCps into OCas, thus enabling the process to be sustained.
Further towards the back of the BMU, the concentration of
TGFβ drops [41]. This facilitates the differentiation of OBps
into OBas [2, 3]. At this point, bone formation starts and the
cavity refills.
The shape of the cell distribution profile of active os-
teoblasts (OBa) is appreciably modified compared to Ref. [41,
Fig. 2] due to the additional influences on osteoblast devel-
opment considered. The increase in the density of OBas is
sharper at the start of formation whilst its decrease towards
the back of the BMU is slower, exhibiting a pseudo-linear
behaviour that contrasts with the exponential-like decrease
obtained in [41]. This slower decrease is attributable to the
tendency of cavity shrinkage to concentrate the density of
active osteoblasts, which partly compensates the depletion
pathways of the pool of active osteoblasts [54]. This enabled
us to calibrate the model so as to match Marotti et al.’s data
on the surface density ρOBa reasonably well.
The strong influence of cavity shrinkage on ρOBa can be
guessed by the fact that during refilling, the surface area of
the BMU cavity walls shrinks to about 20% of its initial extent
(ratio RH/Rc). If the number of osteoblasts was conserved
during refilling, their density would increase five-fold as they
would be packed onto a much smaller surface. Osteoblast
density still decreases due to their continuous elimination
from the active pool, but at rate slowed down by the shrinking
of the cavity.
Model robustness. The biochemical positive feedback loop
between osteoblasts and osteoclasts is controlled (i) by elim-
ination of the cell populations; (ii) by the negative feedback
of TGFβ on the population of osteoclasts (see Figure 2); and
(iii) by the fact that ligand activations saturate when all the
receptors on the cell membranes are occupied. As a conse-
quence, the qualitative behaviour of the model is generally
very robust, unless drastic changes in the model structure are
made (such as swapping the osteoblast cell types expressing
RANKL and OPG, or changing the cell transport properties,
see [41]). The inclusion of geometrical feedbacks on the
osteoblast lineage (through secretory activity and osteocyte
generation) can lead in some cases to more pronounced, but
still continous, changes in the density of active osteoblasts.
These changes are due to the sudden drop in secretory activity
when R ≈ RH , which is accompanied by a sudden drop in
the rate of osteoblast-to-osteocyte transition (since refilling
is terminating). This can lead to a temporary increase in
the density of active osteoblasts when their density is high
(higher than the experimental data points of [21]). At normal
densities, this phenomenon is manifested by a slight “bulge”
in the density distribution near the osteoblast-to-osteocyte
transition (Figure 3c).
BMU initiation and quasi-steady state. The life history of
a BMU is usually divided into three separate stages: initiation
(resorption alone, early life), progression (resorption and
formation, mid life), and termination (formation alone, late
life) [11]. From the dynamics of cell development observed
in our model, these stages can be decomposed further into
several levels of quasi-steady states until the progression stage
is fully developed. Indeed, whilst the population of certain
cell types may have reached a quasi-steady state within the
BMU, the population of other cell types may still be devel-
oping. Due to the longer lifespan of osteoblasts compared to
osteoclasts, we observe that osteoclast densities reach a steady
state earlier in the BMU’s life than osteoblast densities. The
sequence of cell types reaching a steady-state spatial distribu-
tion within the BMU is: (1) precursor cells (OBu, OCp) (this is
assumed to occur instantly [41]); (2) active osteoclasts (OCa);
(3) pre-osteoblasts (OBp); (4) active osteoblasts (OBa). The
appearance of the first active osteoblasts in the BMU (which
denotes the transition from the initiation to the progression
stage according to the usual picture) occurs between stages
(1) and (2). In Figure 3b (at t = 75 days), the density of active
osteoclasts (OCa) and of pre-osteoblasts (OBp) have already
reached a quasi-steady state distribution, but not the density of
OBas near the back of the BMU. This state is situated between
the stages (3) and (4) above, and corresponds to an early (still
developing) progression stage.
According to this picture of cell and BMU development, a
significant portion of the BMU’s lifespan of 6–12 months [2]
could be spent in a developing (nonsteady) stage. The sta-
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bilisation of the spatial distribution profiles of cells occurs
only once the BMU has travelled sufficiently far away from
its point of origin (≈ 130 days). The temporal pattern of
cells experienced at a single location in bone stabilises quicker
(50 days). Unfortunately, this temporal pattern is not recorded
in bone, unlike the spatial distribution of cells. The often
depicted correspondence between temporal pattern at a fixed
location and spatial distribution at a single time (see, e.g., [2,
Figs 1–2]) occurs only once the BMU has fully developed
stable spatial distributions of all its cell types. This could have
important consequences for BMU-related properties of bone
remodelling that are determined experimentally assuming
steady-state BMUs, such as resorption and formation periods
and activation frequencies [1, 11].
Osteoblast-to-osteocyte transition. The generation of os-
teocytes occurs by embedment of active osteoblasts into the
bone matrix [22, 53]. This complex process is believed to
involve a regulation of osteoblast secretory activity by the
osteocytes themselves (e.g., via sclerostin). In the model,
such a regulation is not accounted for, but the rate at which
the osteoblast-to-osteocyte transition needs to occur so as to
reproduce a given distribution of osteocytes is calculated (see
Eq. (17)). Since both matrix apposition rate and BMU cavity
radius decrease as refilling proceeds, the rate of the osteoblast-
to-osteocyte transition (17) also decreases. A regulation
by osteocytes combined with changes in the local curvature
could explain this decrease [27]. However further studies
are required to investigate the effect of potentially important
factors, such as the mineralisation of the newly deposited
matrix.
Osteoblast-to-bone lining cell transition. What regulates
the transition from osteoblasts to quiescent bone lining cells
at the back of a BMU remains poorly understood. In the
model, this transition is driven by the current BMU cavity
radius (via kform in Eq. (8)). A validation of our model
of osteoblast development and of its calibration is provided
by the fact that this transition occurs precisely where ρOBa
reaches observed values of bone lining cells surface densities
(ρLC ≈ 2300/mm2 [11]). This is indicated in Figure 3c by
the fact that the ρOBa curve intersects the OBa→ LC transition
arrow. When the distribution of active osteoblasts did not
match the experimental points of [21] in Figure 3 due to
poorly-calibrated model parameters, the following situations
were encountered. For higher osteoblast densities, the cavity
was refilled earlier, leading to lengths of the closing cone
shorter than reported values, and to an osteoblast-to-bone
lining cell transition occurring at surface densities higher than
2300/mm2. For lower osteoblast densities, the BMU cavity
was either (i) refilled later, leading to lengths of the closing
cone larger than reported value and to an osteoblast-to-bone
lining cell transition occurring at surface densities smaller
than 2300/mm2; or (ii) permanently under-refilled (i.e., not
refilled up to the ‘target’ Haversian canal radius RH ) due the
population of osteoblasts becoming extinct before they could
reduce their secretory activity and become lining cells.
Osteoblast apoptosis. Osteoblast apoptosis in a BMU is
believed to serve to eliminate ‘surplus’ osteoblasts, i.e., os-
teoblasts that are neither forming bone, nor becoming os-
teocytes, nor becoming bone lining cells [2]. The rate of
osteoblast apoptosis, as a regulatory mechanism of osteoblast
number in the closing cone, is thus likely to depend on the
phase of the refilling process in the BMU. As the cavity
shrinks, the number of osteocytes to be generated per unit time
decreases and osteoblasts are confined into a smaller volume,
resulting in an increase in surplus osteoblasts. The rate of
osteoblast apoptosis AOBa OBa assumed in our model, which
is proportional to the population size, enabled us to obtain
a profile of active osteoblast surface density that accurately
matched the experimental measurements of Marotti et al. [21]
and the bone lining cell density. It is possible that comparison
with more extensive data in the future may require AOBa to be
dependent on the refilling stage (e.g., via R).
Number of osteoblasts within the BMU. Precise estimates
of the total number of active osteoblasts in a BMU NOBa are
difficult to find in the literature. Numbers of about 3000
per millimetre of BMU length [36], in the range of 2000–
4000 [43], and up to 6750 [11, Table 6] are reported. This
variation may reflect cross-sectional variability, cross-species
variability, and/or measurements performed on BMUs at dif-
ferent stages of their lifetime, and so having different closing
cone lengths. Estimates of the local surface density of active
osteoblasts ρOBa are likely to be more reliable as they are based
on local measurements and do not depend on the closing cone
length.
A reasonable lower bound estimate of NOBa may be found
by assuming a conical shape of the closing cone between
RH and Rc, and a lower-bound surface density of 2300/mm2
(surface density of bone lining cells [11]). With a closing
cone length Lform ≈ 2.5 mm [11], this provides the lower
bound NOBa & 2170. Following Parfitt [11], a reasonable
upper-bound estimate may be found by assuming a maximum
cavity–bone area given by that of a cylinder of radius Rc
and an average surface density ρOBa ≈ 4500/mm2. This
provides the upper bound NOBa . 7000. The total number
of active osteoblasts in the steady-state BMU obtained in our
simulations (NOBa ≈ 5200) falls well in the above range.
The total number of pre-osteoblasts in the BMU in our
simulations (NOBp ≈ 11100) may seem high, although we are
not aware of pre-osteoblast cell counts in BMUs reported in
the literature. The high value obtained for NOBp compared
to NOBa is mainly due to the integration of OBp across the
whole cavity area S(x, t), as opposed to the integration of OBa
across SOBa(x, t) only. We note, however, that the fate of all
pre-osteoblasts in the model is to become active osteoblasts
at some point of the refilling process, i.e. pre-osteoblasts are
not assumed to undergo apoptosis. In fact, the number of
pre-osteoblasts in a cross-sectional slice of thickness ∆x =
hOBa = 15 µm at a fixed position in bone reaches a maximum
value of about 390 near the start of the refilling process,
then quickly decreases to zero as all of these pre-osteoblasts
become active. This activation process forms a layer of active
osteoblasts against the bone surface with precisely the correct
surface density, as indicated by the match of the surface
density of active osteoblasts ρOBa with the experimental data
in Figure 3c. This shows that in terms of cell densities, the
model is well calibrated, but that absolute number of cells
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derived from the model by integration of the densities may
be estimated with large variabilities depending on the length
of the closing cone.
Shape of the BMU cavity (closing cone) and Haversian
canal. The BMU cavity shown below each plot in Figure 3a–
c is representative of the closing cone and final Haversian
canal. The cutting cone was not calculated in this model
because its shape depends on the movement pattern of osteo-
clasts within the BMU [42].
There is not much quantitative data available on the shape
of the closing cone. Longitudinal BMU sections provide an
inaccurate picture of the closing cone due to section obliquity.
Micro-computed tomography techniques reveal the three-
dimensional shape of intracortical porosities, but are unable to
distinguish quiescent surfaces (Haversian canals) from active
surfaces (BMU cavities) [61]. The length of the closing cone
obtained in our simulations (around 2.5 mm) corresponds to
values estimated for humans [11].
The Haversian canal left after the passage of a BMU has
local dimensions that depend on the stage of the BMU’s life ex-
perienced at each location. The extent of both resorption and
formation depends on whether osteoclasts and/or osteoblasts
have reached a quasi-steady state. If quasi-steady states are
reached in a sequence as our model suggests, some regions
of bone may experience the full extent of resorption but not
the full extent of formation. This situation occurs in our
simulations near x = −4.65 mm in Figure 3a–c, where a
mature osteoclastic front is experienced, but the initial cavity
is only partially refilled because the population of osteoblasts
has not fully developed. This creates a local enlargement of
the Haversian canal that may be contributing to local spatial
nonuniformities observed in Haversian canal sizes [11,61,62].
The observation of such local enlargements may be useful for
the determination of a BMU’s point of origin from micro-CT
scans exhibiting Haversian porosities [61].
Comparison with tetracycline double labelling data.
Tetracycline label radii are usually measured on a collection
of different osteons, rather than on serial sections of a single
osteon [15, 16, 20]. Having observed great cross-sectional
variations of cement line radii and Haversian canal radii, the
authors of Ref. [20] have presented MAR versus the per-
centage of unfilled bone to normalise the data from different
osteons.
The refilling dynamics of our model is remarkably con-
sistent with this data, but also emphasises some important
differences (Figure 4). For the most part, the numerical curves
MAR versus R1 are pseudo-linear. The continuation of the
pseudo-linear segment of the solid black curve (corresponding
to a steady-state BMU) reaches a point near the origin, and
so is in support of the linear phenomenological relationship
between MAR and R, Eq. (2). However, the tetracycline data
in Figure 4 does not reflect the dynamics of refilling of our
model at the start of refilling (R ≈ Rc) and at the end of
refilling (R ≈ RH). At these radii, the relationship between
MAR and R exhibited by the model is clearly nonlinear and
deviates significantly from Eq. (2). In fact, Eq. (2) is satified
by the point R = 0,MAR = 0, but this point is not physiolog-
ically valid since BMUs stop refilling at the Haversian canal
radius. In our model, the sharp increase of MAR near Rc is
due to the sharp rise in active osteoblast number. The sharp
decrease of MAR near RH is due to the secretory activity of
osteoblasts quickly dropping near RH. Similar remarks apply
to the numerical curves shown in Figure 5. The start and
end of refilling formally correspond to points on the diagonal
at Rc and RH, respectively. A pseudo-linear behaviour is
observed for a significant part of the numerical curves. The
continuation of the pseudo-linear segment passes near the
origin (R= 0), consistently with Eq. (2) and other tetracycline
data [16]. The regions of nonlinearities are associated with
the sharp increase and decrease of MAR at the start and end
of formation. The fact that these sharp transitions in MAR
are not reflected in the experimental data suggests that they
occur rapidly, perhaps as a synchronised event amonsts all the
osteoblasts [11]. A synchronised halt of formation may allow
the BMU cavity to reach a target size more consistently. One
potential mechanism is that osteoblasts sense the proximity of
the blood vessel or other localised components, as suggested
e.g. in Ref. [25].
Despite data normalisation to reduce cross-sectional vari-
ability, another source of variability is manifestly present in
the data from Ref. [20]. Our model suggests that the stage
of the BMU’s life at which the data is collected could be an
important contributor to such variability. In Figure 4, we show
numerical curves obtained from regions of bone experiencing
different stages of the BMU’s life history. Bone near x ≈
−4.65 mm experiences the passage of the BMU in an early
progression stage, with a fully-developed population of os-
teoclasts but a non-fully-developed population of osteoblasts.
Bone at x & −3.5 mm experiences the passage of a BMU in
which all cell profiles have reached a quasi-steady state. This
is indicated by the fact that the curve at x = −2.5 mm in
Figure 4 overlaps with the curve at x = −3.5mm. (The curve
is incomplete compared to that at x =−3.5 mm because bone
located at x = −2.5 mm does not experience the passage of
the back of the BMU by t = 150 days.) A possible explanation
of the variability of the experimental data [20] is therefore
that this data may have been collected from BMUs at different
stages of their development. The great variability observed
in cement line radii is consistent with this hypothesis [20].
If so, the frequency of data points lying on curves obtained
from different stages of the BMUs in Figure 4 may enable
an experimental determination of the relative duration of
these stages, much in the same way that the frequency of
BMUs seen in a resorption or formation phase in histological
cross sections enables the experimental determination of the
duration of the resorption and formation phases [1].
Choosing different time intervals between the tetracycline
injections has a marked effect on the slope of the pseudo-
linear behaviour between MAR and R1 or between R2 and
R1 [16]. In Figure 4, there is an appreciable difference
between the approximate matrix apposition rates MAR =∣∣R(x,t+∆t)−R(x,t)
∆t
∣∣ calculated with ∆t = 10 days and the instanta-
neous matrix apposition rate | ∂∂ t R(x, t)| formally correspond-
ing to the limiting case ∆t → 0. The effect of choosing
different ∆t is also shown in Figure 5. Interestingly, this
choice does not particularly affect the extent of the pseudo-
linear behaviour.
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Osteoblast secretory activity. The scarcity of experimental
data on the secretory activity of individual osteoblasts in
bone remodelling is perhaps surprising given that it may
easily be determined by means of Eq. (1), combined with
measurements of osteoblast surface densities and matrix ap-
position rates [21, 28]. The use of generalisation of Eq. (1) to
investigate tetracycline data from irregular BMUs, e.g. Eq. (4),
may help explore the start of the refilling phase in BMU, when
cavity shape can be very irregular [16, 26]. Slightly irregular
osteons were analysed in Ref. [16], but discarded from further
analysis as they did not fit Eq. (2).
In our model, osteoid secretion rate kform is determined by
the current BMU cavity radius R, Eq. (8). The local curvature
of the bone substrate may influence osteoblast membrane
stress [25], integrin connections between neighbouring os-
teoblasts, and/or the transmission of osteocytic signals [27,
29]. This may influence in turn the osteoblasts’ shape,
size, and so their secretory activity [21, 26]. A biological
advantage of a secretory activity effectively regulated by R
is that BMU refilling becomes self-regulated: formation stops
when refilling is complete. However, completion of refilling
also requires that the population of active osteoblasts can be
sustained long enough.
More elaborate models of osteoblast secretory activity
kform(x, t) could be formulated to investigate the refilling
dynamics of BMUs. For example, short-term fluctuations in
matrix apposition rates have been shown to occur both in
animal models (24-hr to 72-hr period) and in humans (10-12
days period) [1, 11, and Refs cited therein]. Bone formation
may also occasionally come to a complete rest for a long
period (of the order of months), particularly with aging and
in some metabolic bone diseases [11], or to exhibit work–
rest cycles [1]. Osteoblast secretory activity is intimately
linked with the bone matrix microstructure [52, 54]. Some
authors have proposed to link work–rest cycles or different
generations of osteoblasts with the lamellar microstructure
of the bone matrix. These hypotheses have been debated
extensively in the literature, see e.g. [1, 11, 52, 54]. Further
insights into these questions would necessitate considerable
elaborations of our computational model.
5 Conclusions
Variations of matrix apposition rates during BMU cavity re-
filling were investigated in a mathematical model of cell
development in a cortical BMU.
The model accounts for significant influences of the evolv-
ing cavity geometry on the density of osteoblasts. These
influences moderate the decrease in osteoblast density towards
the back of the BMU, and enabled us to (i) calibrate the
model against experimental osteoblast densities determined
at three BMU cavity radii; (ii) retrieve matrix apposition
rates decreasing linearly with BMU cavity radius as observed
experimentally (Eq. (2), Figure 4).
A significant portion of a BMU’s lifespan could be spent in a
nonsteady state, due to the long period required for osteoblasts
to reach a steady-state distribution. This may have important
repercussions for BMU-related properties of bone remodelling
derived under the steady-state assumption, such as resorption
and formation periods, and BMU activation frequency [1].
Osteoclast development was found to occur on a much faster
timescale than osteoblast development. Portions of bone in a
BMU’s path may thus experience the full extent of resorption
but a partial extent of formation, which could lead to local
enlargements of Haversian canals near the BMU’s point of
origin.
The direct comparison of our model’s prediction of matrix
apposition rates with tetracycline data suggest that this data
does not exhibit the start and the end of refilling in a BMU.
The build up of osteoblasts at the onset of refilling and their
transition to non-synthesising bone lining cells at completion
of refilling should be associated with low matrix apposition
rates. The fact that this is not observed experimentally may
indicate that these processes occur rapidly, as suggested by
our model. Our model also suggests that a significant part of
the cross-sectional variability remaining in tetracycline data
after their normalisation in Ref. [20, Fig. 2] may be explained
by this data having been collected from BMUs at different
stages of their lifetime.
A complete quantitative picture of the spatio-temporal dy-
namics of BMUs based on experimental measurements remains
to be elucidated. Whilst matrix apposition rates are often
reported in the literature from tetracycline double labelling
experiments, these data integrate both osteoblast number and
osteoblast secretory activity. Furthermore, large and irregular
BMUs, likely to be in an early stage of refilling, are often
discarded [16]. This difficulty could be alleviated by using
Eq. (4), valid for any BMU shape, rather than Eq. (1), valid for
cylindrical BMUs. Experimental knowledge of the secretory
activity of single osteoblasts is scarce, particularly in relation
to a BMU’s internal organisation. The determination of cell
densitites and their distribution along the different phases of
the BMU is essential to gain insights into the biochemical
regulation of individual cells within the BMU. Insights into
these processes are particularly relevant for our understanding
of several bone diseases, including osteoporosis [8].
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Appendix A Model description
In this appendix, we detail some aspects of the model pre-
sented in the Methods section (Section 2). The governing
equations of all cells and signalling molecules considered in
the model are presented, as well as a table listing all the model
parameters.
Osteoblast secretory activity. In cortical BMUs, the se-
cretory activity of single osteoblasts varies as refilling pro-
ceeds [1, 11, 21, 23, 24]. The secretion rate depends on the
amount of organelles involved in glycoprotein and protein
synthesis, and so is likely to depend on the cell’s protoplasmic
volume. The precise factors that influence osteoid secretion
rate are currently not well known, but may include nutrients,
hormones and regulatory molecules [2, 3, 63], and the local
curvature of the cavity [25, 26].
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Table 1 – Osteoid secretion rate vs BMU cavity radius (in dogs)
Rdog [µm] kdogform [µm
3/day]
15 0
17 90
31 103
65 180
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Figure 6 – Assumed functional relationship k˜form(R) (8) bewteen osteoid
secretion rate kform and BMU cavity radius R (solid line). Data points (crosses)
are taken from Table 1 and scaled according to Eqs (20), (21).
To account for the variation of osteoid secretion rate dur-
ing refilling in our model, we assume that kform depends
on the current radius of the cavity (Eq. (8)): kform(x, t) =
k˜form
(
R(x, t)
)
, with k˜form(RH) = 0, where RH is the Haver-
sian canal radius at which osteoblasts have become (non-
synthesising) bone lining cells (Figure 1b). Marotti et al. [21]
reported osteoid secretion rates at three different radii in
canine cortical BMUs. We add to this data a zero secretion
rate at RHdog ≈ 15 µm, the average Haversian canal radius
in dogs [11] (see Table 1). The data of Table 1 is used
to generate pseudo-human data by appropriate scalings as
explained in the paragraph Scaling data from animal models
to humans below. The pseudo-human data is then interpolated
by a continuous piecewise polynomial curve k˜form(R) that
has a sharp stepwise increase between R = RH = 20 µm and
R = 22 µm, and a linear slope for R ≥ 22 µm, as depicted
in Figure 6. Note that all the active osteoblasts in the cross-
section at x secrete at the same rate kform(x, t). As long as
the cavity radius R is larger than the ‘target’ Haversian canal
radius RH , the activity of osteoblasts is therefore assumed
continuous and uninterrupted, which is probably the most
common pattern of bone refilling in cortical BMU, at least in an
average sense (see also comments in Section 4) [1,11,52,54].
Osteoblast-to-bone lining cell transition. At the end of
the formation phase at the back of a BMU, active osteoblasts
terminally differentiate into bone lining cells, thus forming a
cellular layer on the newly formed bone surface [1, 11]. To
account for such a transition in the model while ensuring the
spatial exclusion of active osteoblasts and bone lining cells,
we assume that active osteoblasts whose osteoid secretion
rate kform is rapidly dropping become bone lining cells. This
occurs between cavity radii 20–22 µm (Figure 6).
Osteoblast-to-osteocyte transition. A fraction of active os-
teoblasts is entrapped in the new bone matrix during bone
formation and becomes osteocytes [22, 29, 53]. This is rep-
resented by the sink term −σprod.OCY (x, t) in Eq. (10). Here,
we determine what rate of osteocyte generation σprod.OCY (x, t)
(density produced per unit time) reproduces a given osteocyte
density in cortical BMUs, OCYexp.(x,r) (e.g., one determined
experimentally). We allow for a possible dependence upon
the radial coordinate r in the cross section (Figure 1b).
The correspondence between OCYexp. and σ
prod.
OCY is found by
calculating the number of osteocytes in the slice of thickness
∆x at time t, ∆NOCY(x, t). This number increases during bone
deposition from zero at the onset of bone refilling (t = tF)
(Figure 1b, stage 1) to a constant final number at the end
of bone refilling (Figure 1b, stage 4). At any time t in
between, ∆NOCY(x, t) is given by (i) integrating spatially the
given density OCYexp. from Rc to R(x, t) (Figure 1b); or (ii)
integrating temporally the production rate σprod.OCY from tF to t.
Equating these integrations gives:
2pi
∫ Rc
R(x,t)
dr r OCYexp.(x,r) =
∫ t
tF
dt ′(σprod.OCY SOBa)(x, t
′).
The dependence upon t occurs in the integral bounds. From
standard calculus, the differentiation of the above equation
with respect to t is given by the integrant evaluated at the
time-dependent bound times the derivative of the bound (with
a negative sign for the lower bound). Thus:
−2piR(x, t)OCYexp.
(
x,R(x, t)
) ∂
∂ t R(x, t)
= σprod.OCY (x, t)SOBa(x, t).
Using Eq. (6) to substitute ∂∂ t R and then Eq. (11) to substitute
ρOBa/SOBa , one finds:
σprod.OCY (x, t) = 2pi R OCYexp. kform
ρOBa
SOBa
= kform(x, t)OBa(x, t) OCYexp.
(
x,R(x, t)
)
(17)
Geometric influence of BMU cavity shrinkage. The ten-
dency of cavity shrinkage to concentrate the density of os-
teoblasts is represented by the source term GOBa in Eq. (10).
To determine the form of G(x, t), we consider the num-
ber of active osteoblasts in the slice at x of thickness ∆x,
∆NOBa(x, t) = OBa ∗SOBa ∆x. The rate of change of this number
is ∂∂ t∆NOBa(x, t) =
[
( ∂∂ t OBa)SOBa +OBa
∂
∂ t SOBa
]
∆x. Within the
slice, ∆NOBa can only be modified by biological creation or
elimination, which is described by the source and sink terms
DOBp OBp − AOBa OBa − σprod.OCY ≡ ∂∂ t OBa−G OBa in Eq. (10).
Hence:
∂
∂ t∆NOBa =
[
( ∂∂ t OBa)SOBa +OBa
∂
∂ t SOBa
]
∆x
=
[
∂
∂ t OBa−G OBa
]
SOBa ∆x. (18)
Dividing by OBa ∗SOBa ∆x, this gives:
G(x, t) =−
∂
∂ t SOBa(x, t)
SOBa(x, t)
=−
∂
∂ t R(x, t)
R(x, t)
(
1− hOBa2R(x,t)
)
=−kform(x, t)OBa(x, t) hOBaR(x, t) , (19)
where Eqs (12) and (14) were used for the last equalities.
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Table 2 – Osteoblast surface density vs BMU cavity radius (in dogs)
Rdog [µm] ρdogOBa [mm
−2]
17 4500
31 8770
65 10000
Scaling data from animal models to humans. To calibrate
our model to a human cortical BMU, we scale BMU-related
data obtained from animal models according to known (or
suspected) cross-species differences.
The BMU cavity radius data Rdog from Table 1 was scaled
to (pseudo-)human values R by assuming a linear relationship
R=R(Rdog) such that R(RHdog)=RH and R(Rcdog)=Rc. This
gives:
R(Rdog) = RH+
Rc−RH
Rcdog−RHdog
(Rdog−RHdog). (20)
We used the typical values RHdog ≈ 15 µm and RH ≈ 20 µm
for canine and human Haversian canal radii. In Ref. [11],
the average cement line radius in dogs is Rcdog ≈ 60 µm. In
Ref. [59], it is Rcdog ≈ 77 µm. Since one of the three BMU
cavities in Ref. [21] has a radius 65 µm in the formation phase,
we take here 70 µm as the representative canine cement line
radius. We used the value Rc ≈ 100 µm for the human cement
line radius [1, 11, 59].
The osteoid secretion rates kdogform of Table 1 estimated by
Marotti et al. [21] were scaled by a factor αkform = 1.25 to
account for higher secretion rates in humans [36], i.e.:
kform = αkform k
dog
form. (21)
The model of Polig and Jee [36] suggests that αkform may take
values from 1.27 to 1.7. Here, the specific numerical value
of the factor αkform is chosen so as to reduce the total number
of active osteoblasts in the BMU (see Results and Discussion,
Sections 3,4). The scaled radius and osteoid secretion rate
data of Table 1 are shown in Figure 6 (crosses).
Scalings are also applied to the data of Table 2 reporting
canine osteoblast surface densities ρdogOBa at three BMU cavity
radii. The radii Rdog are scaled to correspond to human
average BMUs as in Eq. (20). The osteoblast surface densities
ρdogOBa are scaled to pseudo-human data as ρOBa = α
−1
kform
ρdogOBa .
The choice of the scaling factor α−1kform = 0.8 is motivated by
the corresponding scaling factor αkform = 1.25 performed on
kdogform. Indeed, increased osteoid secretion rate is associated
with increased cell volume, and thus with a corresponding
decrease in cell density [21, 24].
Scaling of the cell density distributions in the BMU. The
cell distribution profiles along x resulting from the numeri-
cal simulation are calibrated against experimental values of
osteoblast surface densities and total cell numbers. To this
end, we have modified the values of a number of parameters
compared to the parameters used in Ref. [41]. We used a
scaling scheme of the model parameters such that OBa, OBp,
OBu, OCa and OBp would scale uniformly without affecting
much their own spatial distribution and without affecting their
spatial relation with other cell density profiles. We defined
scaling factors αOBa , αOBp , αOBu , αOCa and αOCp , such that
if αOBa = 500, the density of OBas is multiplied by a factor
500 etc. Based on Eqs (23)–(26), the new parameter values
(denoted below by a prime) ensuring such scaled densities
were determined by multiplying the previous parameter values
(non-primed) with an adequate combination of the above
scaling factors, according to:
OBmaxu
′ = αOBu OB
max
u , OC
max
p
′ = αOCp OC
max
p ,
D′OBu =
αOBp
αOBu
DOBu , D
′
OCp =
αOCa
αOCp
DOCp ,
nbone
′
TGFβ = n
bone
TGFβ/αOCa , N
RANK′
OCp = N
RANK
OCp /αOCp ,
βRANKL
′
OBp = β
RANKL
OBp /αOBp , β
OPG′
OBa = β
OPG
OBa /αOBa , (22)
where OBmaxu and OC
max
p denote parameters scaling the given
distributions of OBus and OCps [41]. We note that it is not
possible to control the scaling of OBp independently from that
of OBa without affecting their spatial relationship, and so we
have always taken αOBp = αOBa when calibrating the model.
Governing equations of cell densities and signalling
molecules concentrations. Below we summarise all the
governing equations of the model. The material balance equa-
tion governing the dynamics of active osteoblasts, Eq. (10), is
rewritten using the explicit expressions in Eqs (17) and (19):
∂
∂ t OCa =DOCp(RANKL)OCp−AOCa(TGFβ)OCa− ∂∂x
(
OCavOCa
)
,
∂
∂ t OBp =DOBu(TGFβ)OBu−DOBp(TGFβ)OBp,
∂
∂ t OBa =DOBp(TGFβ)OBp−AOBa OBa
+ kform OBa
[
hOBa
R OBa−OCYexp.
(
x,R
)]
,
∂
∂ t TGFβ=n
bone
TGFβ kres OCa−DTGFβ TGFβ, (23)
where
DOCp(RANKL) = DOCppi
act(RANKL
kRANKLOCp
)
,
AOCa(TGFβ) = AOCapi
act( TGFβ
kTGFβOCa
)
,
DOBu(TGFβ) = DOBupi
act( TGFβ
kTGFβOBu
)
,
DOBp(TGFβ) = DOBppi
rep( TGFβ
kTGFβOBp
)
, (24)
and
PTH(x, t) =βPTH/DPTH,
RANK(x, t) =NRANKOCp OCp,
OPG(x, t) =
βOPGOBa OBapi
rep
(
PTH
kPTHOB,rep
)
βOPGOBa OBapi rep
(
PTH
kPTHOB,rep
)
/OPGsat+DOPG
RANKL(x, t) =
βRANKLOBp OBp
1+ kRANKLRANK RANK+ kRANKLOPG OPG
×
{
DRANKL +
βRANKLOBp OBp
NRANKLOBp OBp piact
(
PTH
kPTHOB,act
)}−1 .
(25)
The density distributions OBu(x, t) and OCp(x, t) are assumed
to be given functions (see Table 3). The dimensionless func-
tions piact and pi rep express the activation and repression of cell
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differentiation, apoptosis, or ligand expression by regulatory
signalling molecules. These functions are determined by the
fraction of receptors on the cell occupied by the concerned
signalling molecules (see Refs [31,41]). Mathematically, they
are so-called Hill functions given by:
piact(ξ ) =
ξ
1+ξ
, pi rep(ξ ) = 1−piact(ξ ) = 1
1+ξ
. (26)
A slight change in the expression for RANKL in Eq. (25)
has been made compared to Ref. [41]. The production of
RANKL is now correctly proportional to the number of cells
that express RANKL, i.e., we have replaced βRANKL in Ref. [41,
Eq. (19)] by βRANKLOBp OBp in Eq. (25). The same inconsistency
of having a production rate of RANKL not scaled by the number
of osteoblasts is present in the temporal model of Ref. [31],
which was corrected in Ref. [33]. The behaviour of the
BMU model is not changed significantly by this correction.
Some inconsistent behaviours of the temporal model [31]
were corrected by this change, see Ref. [33] for more details.
BMU model parameters and functions. All the parameters
used in the model are listed in Table 3. Several parameters
were taken over from the temporal model of bone remodelling
of Refs [31, 33] and our previous model of the BMU [41] (see
last column of Table 3). We emphasise that rate parameters for
cell differentiation/apoptosis are weighted by Hill functions
of the concentration of signalling molecules, Eqs (24), which
vary themselves in space and time. These rate parameters
were therefore calibrated to known BMU characteristics that
they determine, and should not be viewed as the actual value
of the differentiation/apoptosis rates. For example, AOCa was
chosen such that the OCa population reaches a steady state
within 10 days (corresponding to the lifespan of osteoclast
nuclei in active osteoclasts [43]), but 1/AOCa 6= 10 days.
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Table 3 – BMU model parameters and given functions
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k˜form(R) (given function) volume of osteoid secreted per osteoblast per day Extrapolated from [21] (see Eq. (8) and
Figure 6)
DOCp 41.26/day OCp→ OCa differentiation rate parameter Calibration for NOCp , NOCa , Eqs (22)
AOCa 2.82/day OCa apoptosis rate parameter [41] (calibrated for OCas to reach steady
state within 10 days (≈ lifespan of osteo-
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